{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:17:43Z","timestamp":1761394663539,"version":"3.37.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.14310\/horm.2002.1585","type":"journal-article","created":{"date-parts":[[2015,6,28]],"date-time":"2015-06-28T09:43:13Z","timestamp":1435484593000},"page":"317-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Familial partial lipodystrophy type 3: a new mutation on the PPARG gene"],"prefix":"10.1007","volume":"14","author":[{"given":"Eva","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,1]]},"reference":[{"key":"14020317_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ecl.2004.03.003","volume":"33","author":"A Garg","year":"2004","unstructured":"Garg A, Misra A, 2004 Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinol Metab Clin North Am 33: 305\u2013331.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"14020317_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bbalip.2008.12.014","volume":"1791","author":"A Garg","year":"2009","unstructured":"Garg A, Agarwal AK, 2009 Lipodystrophies: Disorders of adipose tissue biology. Biochim Biophys Acta 1791: 507\u2013513.","journal-title":"Biochim Biophys Acta"},{"key":"14020317_CR3","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","volume":"87","author":"W Haque","year":"2002","unstructured":"Haque W, Shimomura I, Matsuzawa Y, Garg A, 2002 Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 87: 2395\u20132398.","journal-title":"J Clin Endocrinol Metab"},{"key":"14020317_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ng0398-292","volume":"18","author":"JM Peters","year":"1998","unstructured":"Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM, Garg A, 1998 Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat Genet 18: 292\u2013295.","journal-title":"Nat Genet"},{"key":"14020317_CR5","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1210\/jc.2011-1159","volume":"96","author":"A Garg","year":"2011","unstructured":"Garg A, 2011 Lipodystrophies: Genetic and Acquired Body Fat Disorders. J Clin Endocrinol Metab 96: 3313\u20133325.","journal-title":"J Clin Endocrinol Metab"},{"key":"14020317_CR6","first-page":"1408","volume":"87","author":"A Agarwal","year":"2002","unstructured":"Agarwal A, Garg A, 2002 A Novel Heterozygous Mutation in Peroxisome Proliferator-Activated Receptor-\u03b3 Gene in a Patient with Familial Partial Lipodystrophy. J Clin Endocrinol Metab 87: 1408\u20131411.","journal-title":"J Clin Endocrinol Metab"},{"key":"14020317_CR7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1126\/science.1096706","volume":"304","author":"S George","year":"2004","unstructured":"George S, Rochford JJ, Wolfrum C, et al, 2004 A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304: 1325\u20131328.","journal-title":"Science"},{"key":"14020317_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/emmm.200900037","volume":"1","author":"O Rubio-Cabezas","year":"2009","unstructured":"Rubio-Cabezas O, Puri V, Murano I, et al, 2009 Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med 1: 280\u2013287.","journal-title":"EMBO Mol Med"},{"key":"14020317_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1056\/NEJMoa1007487","volume":"364","author":"S Gandotra","year":"2011","unstructured":"Gandotra S, Le Dour C, Bottomley W, et al, 2011 Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med 364: 740\u2013748.","journal-title":"N Engl J Med"},{"key":"14020317_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/MOL.0b013e32830dd09b","volume":"19","author":"SO Olofsson","year":"2008","unstructured":"Olofsson SO, Bostr\u00f6m P, Andersson L, et al, 2008 Triglyceride containing lipid droplets and lipid droplet-associated proteins. Curr Opin Lipidol 19: 441\u2013447.","journal-title":"Curr Opin Lipidol"},{"key":"14020317_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tem.2010.06.006","volume":"21","author":"E Jeninga","year":"2010","unstructured":"Jeninga E, Kalkhoven E, 2010 Central players in inherited lipodystrophies. Trends Endocrinol Metab 21: 581\u2013588.","journal-title":"Trends Endocrinol Metab"},{"key":"14020317_CR12","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1056\/NEJMra025261","volume":"350","author":"A Garg","year":"2004","unstructured":"Garg A, 2004 Acquired and inherited lipodistrophies. N Engl J Med 350: 1220\u20131234.","journal-title":"N Engl J Med"},{"key":"14020317_CR13","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1210\/jc.2007-2356","volume":"93","author":"G Tan","year":"2008","unstructured":"Tan G, Savage D, Fielding B, et al, 2008 Fatty acid metabolism in patients with ppargamma mutations. J Clin Endocrinol Metab 93: 4462\u20134470.","journal-title":"J Clin Endocrinol Metab"},{"key":"14020317_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jocd.2010.01.005","volume":"13","author":"P Freitas","year":"2010","unstructured":"Freitas P, Santos AC, Carvalho D, et al, 2010 Fat mass ratio: an objective tool to define lipodystrophy in HIV-infected patients under antiretroviral therapy. J Clin Densitom 13: 197\u2013203.","journal-title":"J Clin Densitom"},{"key":"14020317_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ando.2012.04.010","volume":"73","author":"MC Vantyghem","year":"2012","unstructured":"Vantyghem MC, Balavoine AS, Douillard C, et al, 2012 How to diagnose a lipodystrophy syndrome. Ann Endocrinol (Paris) 73: 170\u2013189.","journal-title":"Ann Endocrinol (Paris)"},{"key":"14020317_CR16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.revmed.2012.11.008","volume":"34","author":"L Fardet","year":"2013","unstructured":"Fardet L, Vigouroux C, Capeau J, 2013 Syndromes lipodystrophiques. Rev Med Interne 34: 614\u2013622.","journal-title":"Rev Med Interne"},{"key":"14020317_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1172\/JCI28003","volume":"116","author":"R Semple","year":"2006","unstructured":"Semple R, Chatterjee V, Rahilly S, 2006 PPAR-gamma and human metabolic disease. J Clin Invest 116: 581\u2013589.","journal-title":"J Clin Invest"},{"key":"14020317_CR18","doi-asserted-by":"publisher","first-page":"15712","DOI":"10.1073\/pnas.2536828100","volume":"100","author":"W He","year":"2003","unstructured":"He W, Barak Y, Hevener A, et al, 2003 Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A 100: 15712\u201315717.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14020317_CR19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1017\/S1368980007000614","volume":"10","author":"G Medina-Gomes","year":"2007","unstructured":"Medina-Gomes G, Gray S, Vidal-Puig A, 2007 Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor g (PPARg) and PPARgcoactivator-1 (PGC1). Public Health Nutrition 10: 1132\u20131137.","journal-title":"Public Health Nutrition"},{"key":"14020317_CR20","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1194\/jlr.R700004-JLR200","volume":"48","author":"R Hegele","year":"2007","unstructured":"Hegele R, Joy T, Al-Attar D, Rutt B, 2007 Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res 48: 1433\u20131444.","journal-title":"J Lipid Res"},{"key":"14020317_CR21","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00125-011-2142-4","volume":"54","author":"M Visser","year":"2011","unstructured":"Visser M, Kropman E, Kranendonk, et al, 2011 Characterization of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPAR-gamma mutation (Y151C). Diabetologia 54: 1639\u20131644.","journal-title":"Diabetologia"},{"key":"14020317_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1210\/er.2010-0020","volume":"32","author":"R Semple","year":"2011","unstructured":"Semple R, Savage D, Cochran E, Gorden P, O\u2019Rahilly S, 2011 Genetic syndromes of severe insulin resistance. Endocr Rev 32: 498\u2013514.","journal-title":"Endocr Rev"},{"key":"14020317_CR23","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1210\/jc.2006-1807","volume":"92","author":"H Monajemi","year":"2007","unstructured":"Monajemi H, Zhang L, Li G, et al, 2007 Familial Partial lipodistrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma. J Clin Endocrinol Metab 92: 1606\u20131612.","journal-title":"J Clin Endocrinol Metab"},{"key":"14020317_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/rheumatology\/keg076","volume":"42","author":"UA Walker","year":"2003","unstructured":"Walker UA, Kirschfink M, Peter HH, 2003 Improvement of acquired partial lipodystrophy with rosiglitazone despite ongoing complement activation. Rheumatology 42: 393\u2013394.","journal-title":"Rheumatology"},{"key":"14020317_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","volume":"53","author":"AY Chong","year":"2010","unstructured":"Chong AY, Lupsa BC, Cochran EK, Gorden P, 2010 Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia 53: 27\u201335.","journal-title":"Diabetologia"},{"key":"14020317_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrendo.2010.199","volume":"7","author":"C Fiorenza","year":"2011","unstructured":"Fiorenza C, Chou S, Mantzoros C, 2011 Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol 7: 137\u2013150.","journal-title":"Nat Rev Endocrinol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1585\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:38:43Z","timestamp":1739115523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["14020317"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1585","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"type":"print","value":"1109-3099"},{"type":"electronic","value":"2520-8721"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"23 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}